ÂÜÀòÂÒÂ×

Keith A. Greathouse has over 35 years of industry experience with major pharmaceutical companies. Prior to founding DermAvance, Mr. Greathouse served as executive vice president for Sanofi-Aventis Dermatology (Dermik), where he launched many significant new dermatology products such as Benzamycin, Benzaclin, Carac, Penlac, Klaron, Psorcon, Noritate, Vanamide, and most recently, Sculptra. He has a Bachelor of Arts degree in Marketing from San Jose State University and a Doctorate from New York College of Podiatric Medicine. He currently serves on the boards of the Women’s Dermatologic Foundation and is a trustee and secretary for the Board of Trustees of the New York College of Podiatric Medicine. Mr. Greathouse is active in the following societies: the American Academy Of Dermatology (AAD), the American Society of Dermatologic Surgeons, (ASDS), The Skin Cancer Foundation (SCF), American Academy of Plastic Surgery (AAPS).